3
views
0
recommends
+1 Recommend
2 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      COVID-19 in Wuhan, China: Pressing Realities and City Management

      discussion

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction To most economists around the World, Covid-19 has provided an objective lesson in market failure (1). In the absence of complete information and sometimes even fake news (2), nobody knew what kind of pandemic it was at the beginning. Yet, there were 32,583 patients with laboratory-confirmed Covid-19 in Wuhan between December 8, 2019, and 8 March 8, 2020 (3). The pandemic crippled and continues to cripple many health systems and has created unprecedented pressure on the psychological and physical aspects of millions of people's lives around the world. Over 200 countries and territories suffer from an acute shortage of medical personnel and medical equipment (4). The responses of different countries to Covid-19 has involved a range of measures that reflect national values, politics, and variations in scientific advice provided by local experts. Political considerations have often become more important than science (5). The Covid-19 outbreak in Wuhan was one of the most serious cases amongst all cities in the world, yet Wuhan managed and gain control of this pandemic. Health care systems and policies are important aspects that affect the control of infectious diseases like Covid-19. In China, 98% of primary health-care is complemented by traditional Chinese medicine (TCM) with allopathic approaches (6). Previous research has found that the cure rate increased by 33% among mild cases after adopting TCM with allopathic approaches. The hospital stay of severe patients with TCM's and nucleic acid turning negative was shortened by over 2 days (7). Prior to Covid-19, the government's Healthy China 2030 plan was already addressing chronic diseases in the aging population by raising healthcare expenditure (6). This is in sharp contrast to other countries with aging population problems such as Italy, where the government cut the healthcare budget substantially after the economic downturn. Hospital bed allocation went down from a maximum of four for every thousand inhabitants to a maximum of 3.7 (8), despite the fact that 23.1% of the Italian population were aged 65 years and older in 2020 (9). Likewise, the post-2008 financial crisis in Spain forced severe cuts to healthcare costs, which caused pressure on the system when there was an increase in demand for healthcare services. These measures particularly affected the elderly and disabled who are more vulnerable to Covid-19. Healthcare costs become underfunded at the level of 6.4% of GDP (10). Apart from scientific evidence on the effectiveness of TCM in curing covid, financial expenditures on health care is an important distal factor that helped Wuhan overcome Covid-19 quickly. In the following sections of this paper, we review the three city management stages adopted in Wuhan, to study proximal causes of success in combating the virus: (1) strong government intervention early in the outbreak; (2) the city lockdown; and, (3) the use of digital measures, such as a health code, when the city reopened. Three Stages of COVID-19 in Wuhan Stage 1: December 2019 to January 22, 2020 (Early Covid Outbreak in the Absence of Strong Government Intervention) In December 2019, some cases of “pneumonia of unknown origin” were reported in Wuhan. Chinese health authorities confirmed that this cluster was associated with a coronavirus (11). Most activities took place as normal. By Jan 2, 2020, 41 patients admitted to hospital were identified as having a laboratory-confirmed 2019-nCoV infection. Altogether 27 of these 41 patients had been to the Huanan seafood market between December 8, 2019, and January 2, 2020, and it was then closed on January 1, 2020. One family cluster was found. With the Chunyuan, a massive population flow for the Chinese New Year started on January 10, 2020, and the increase in movement between provinces escalated the transmission of Covid-19 (from January 10 the numbers increased from around 100 cases to 400 cases on January 19, alone). The National Health Commission confirmed human-to-human transmission of Covid-19 on January 20, 2020 (12). The Chinese Health Authorities notified the World Health Organization (WHO) on December 31, 2019, and stepped up border surveillance, prompted by Hong Kong, Macau, and Taiwan (13, 14). At first, a lack of information prevented authorities in China from implementing effective measures, but it was soon established that early warning and traffic restrictions are important measures in controlling the early onset of coronavirus and reducing the spread of the virus to other places. Stage 2: January 23, 2020, to Mid-March 2020 (Close City Management Period) After having over 1,000 covid cases confirmed on January 22 2020 alone, the Wuhan Municipal Government adopted “close city” management on January 23, 2020, meaning nobody could move to Wuhan, and everyone inside the city had to quarantine. Locals began to store food, medicine, and protective equipment (15). Yet, Wuhan had over a 100 cases, which went up by 100 per day on average (as compared to the previous day) from January 10 onwards. From January 22 to February 5 2020, a thousand covid new cases were diagnosed daily on average, reaching the peak of 2,000 1 day on February 1, 2020 (3). The insurmountable number of newly infected patients overloaded the existing 83 hospitals in Wuhan (16) and drove Wuhan to designate several hospitals with 23,532 beds, which admitted only covid patients. New temporary hospitals such as the Huoshenshan Hospital and the Leishenshan Hospital were built to provide an additional 2,600 beds but their capability to treat patients was limited compared to the increase in patients (12) (Appendix in Supplementary Tables 1, 2). This initiative involved 140 medical volunteers from Jiangsu, who arrived in Wuhan on January 23, 2020 (17) and 136 medical volunteers from Shanghai Medical Team Huashan Hospital, Ruijin Hospital, Xinhua Hospital, Chest Hospital, Renji Hospital in Shanghai arrived on January 25, 2020, to relieve the pressure of medical staff in Wuhan (18). Subsequently, over 32,572 volunteer health personnel from other provinces gradually came to Wuhan in this period (19). All residential areas were closed and people from outside could not enter. People sent messages to community WeChat groups or QQ groups (online communities) for the purchase of necessities. Community staff bought these for them or they received free food from the government (source: author's WeChat group in Wuhan). Health policies were tightened quickly in February: Non-residents were forbidden to enter small districts on February, 14. Each household sent one person every 3 days to purchase daily necessities on February, 16. Residents had to measure body temperature twice and sent those that exceeded 37.3°C to medical institutions from February, 17 (15). The effective reproduction number of Covid-19 kept above 3.0 before January 26 and dropped below 1.0 after February 6, and was lower than 0.3 after March 1 (3). March marked the early success of all the measures in combatting Covid-19. Stage 3: Late March to August 2020 (Recovery After Close City Management) In late March, public transportation systems resumed services. Since April 30, 2020, there have been no further newly confirmed, dead, or suspected covid cases. From May 14 to June 1, covid test institutions operated 24-h a day, 10.109 million people in Wuhan completed a Covid-19 test within 19 days. Sixty-three medical institutions, 1,451 testing personnel, and 701 testing equipment were involved. A “Red code” was issued for Covid-19 patients in the health app linked with WeChat and Alipay. If the patient was cured, discharged, and had no recurring symptoms after 14 days of isolation, they received a “yellow code.” After returning home for 14 days, this rating was converted to a “green code.” People with fever and any people closely connected to confirmed covid patients were assigned “yellow codes.” They were given “green codes” after 14 days of quarantine and after they had passed a covid test (15, 20, 21). The three stages of Covid-19 measurement and responses are shown in Figure 1. Figure 1 Three stages of covid-19 measurement (15, 20, 22, 23). Discussion and Conclusions A Choice Between Combating the Virus and Human Rights To reduce the spread of Covid-19 and contain any spread of the infectious disease in the future, early response is essential (24). Most of the policy decisions discussed above were made by government officials who made prompt policies and implemented them quickly, but citizens had no involvement or say in the process. Covid-19 calls for a period of lockdown (25) which successfully prevents the spread of the virus, however, this fails to address human rights (e.g., they cannot go outside easily) and it also amplifies health inequalities (26, 27). Many people from western and other societies consider not wearing masks as a kind of human freedom, however, not wearing masks cannot prevent the spread of Covid-19. Many worried that a resurgence of the disease will happen after the country lifts the strictest control measures, although this is not supported by data as per Figure 1 and health records up to August 2020. The Chinese government implemented extraordinary labor-intensive, large-scale measures (21) like closing Wuhan city in February 2020 and giving 10.109 million people a Covid-19 test over 19 days. This is perhaps “mission impossible” anywhere else, given the requirements and budgets that are required and the fact that it may or may not test human rights. A health code system that utilizes Covid-19 records in Alipay and WeChat was linked with the personal data of all mainland Chinese citizens, including bank accounts and debt records. This approach might not be impossible overseas, due to concerns about the freedom and privacy of individuals. The collection of 6,000 taxis within a day, for moving materials, personnel, and transporting patients is possible in China owing to its socialist political structure. It could be said that this goes against private ownership (a kind of the human rights). None of these actions could happen easily in countries in the west, yet, it was also because of all these controversial non-therapeutic measures that Covid-19 was contained and controlled in a short time. TCM, Budget, and Preparation for the Future The use of TCM together with western medicine and an appropriate budget for healthcare are important distal causes in combating Covid-19. Budget cuts in other countries after the financial crisis has led to a serious healthcare problem, particularly when these systems are faced with an unexpected Covid-19 pandemic. Finally, the outbreak of SARS in 2003 followed by Covid-19 indicates that it is likely that other coronavirus diseases may happen again in the future. Given the high population density in urban areas, large-scale public venues in urban areas should allow open building concepts that allow the existing building infrastructures to be converted to medical emergency centers. Local emergency action plans including sewage and ventilation prerequisites and procedures for renovation should be recorded and revised according to our experience in Wuhan and other places (12). With appropriate leadership and politics, these measures might be adapted to other cities across the globe. Author Contributions RL and XY wrote and collected the data. MJCC revised and edited the whole paper. All authors contributed to the article and approved the submitted version. Conflict of Interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

          Related collections

          Most cited references21

          • Record: found
          • Abstract: found
          • Article: not found

          Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

          Summary Background A recent cluster of pneumonia cases in Wuhan, China, was caused by a novel betacoronavirus, the 2019 novel coronavirus (2019-nCoV). We report the epidemiological, clinical, laboratory, and radiological characteristics and treatment and clinical outcomes of these patients. Methods All patients with suspected 2019-nCoV were admitted to a designated hospital in Wuhan. We prospectively collected and analysed data on patients with laboratory-confirmed 2019-nCoV infection by real-time RT-PCR and next-generation sequencing. Data were obtained with standardised data collection forms shared by WHO and the International Severe Acute Respiratory and Emerging Infection Consortium from electronic medical records. Researchers also directly communicated with patients or their families to ascertain epidemiological and symptom data. Outcomes were also compared between patients who had been admitted to the intensive care unit (ICU) and those who had not. Findings By Jan 2, 2020, 41 admitted hospital patients had been identified as having laboratory-confirmed 2019-nCoV infection. Most of the infected patients were men (30 [73%] of 41); less than half had underlying diseases (13 [32%]), including diabetes (eight [20%]), hypertension (six [15%]), and cardiovascular disease (six [15%]). Median age was 49·0 years (IQR 41·0–58·0). 27 (66%) of 41 patients had been exposed to Huanan seafood market. One family cluster was found. Common symptoms at onset of illness were fever (40 [98%] of 41 patients), cough (31 [76%]), and myalgia or fatigue (18 [44%]); less common symptoms were sputum production (11 [28%] of 39), headache (three [8%] of 38), haemoptysis (two [5%] of 39), and diarrhoea (one [3%] of 38). Dyspnoea developed in 22 (55%) of 40 patients (median time from illness onset to dyspnoea 8·0 days [IQR 5·0–13·0]). 26 (63%) of 41 patients had lymphopenia. All 41 patients had pneumonia with abnormal findings on chest CT. Complications included acute respiratory distress syndrome (12 [29%]), RNAaemia (six [15%]), acute cardiac injury (five [12%]) and secondary infection (four [10%]). 13 (32%) patients were admitted to an ICU and six (15%) died. Compared with non-ICU patients, ICU patients had higher plasma levels of IL2, IL7, IL10, GSCF, IP10, MCP1, MIP1A, and TNFα. Interpretation The 2019-nCoV infection caused clusters of severe respiratory illness similar to severe acute respiratory syndrome coronavirus and was associated with ICU admission and high mortality. Major gaps in our knowledge of the origin, epidemiology, duration of human transmission, and clinical spectrum of disease need fulfilment by future studies. Funding Ministry of Science and Technology, Chinese Academy of Medical Sciences, National Natural Science Foundation of China, and Beijing Municipal Science and Technology Commission.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis

            Highlights • COVID -19 cases are now confirmed in multiple countries. • Assessed the prevalence of comorbidities in infected patients. • Comorbidities are risk factors for severe compared with non-severe patients. • Help the health sector guide vulnerable populations and assess the risk of deterioration.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found

              The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China

              The city of Wuhan in China is the focus of global attention due to an outbreak of a febrile respiratory illness due to a coronavirus 2019-nCoV. In December 2019, there was an outbreak of pneumonia of unknown cause in Wuhan, Hubei province in China, with an epidemiological link to the Huanan Seafood Wholesale Market where there was also sale of live animals. Notification of the WHO on 31 Dec 2019 by the Chinese Health Authorities has prompted health authorities in Hong Kong, Macau, and Taiwan to step up border surveillance, and generated concern and fears that it could mark the emergence of a novel and serious threat to public health (WHO, 2020a, Parr, 2020). The Chinese health authorities have taken prompt public health measures including intensive surveillance, epidemiological investigations, and closure of the market on 1 Jan 2020. SARS-CoV, MERS-CoV, avian influenza, influenza and other common respiratory viruses were ruled out. The Chinese scientists were able to isolate a 2019-nCoV from a patient within a short time on 7 Jan 2020 and perform genome sequencing of the 2019-nCoV. The genetic sequence of the 2019-nCoV has become available to the WHO on 12 Jan 2020 and this has facilitated the laboratories in different countries to produce specific diagnostic PCR tests for detecting the novel infection (WHO, 2020b). The 2019-nCoV is a β CoV of group 2B with at least 70% similarity in genetic sequence to SARS-CoV and has been named 2019-nCoV by the WHO. SARS is a zoonosis caused by SARS-CoV, which first emerged in China in 2002 before spreading to 29 countries/regions in 2003 through a travel-related global outbreak with 8,098 cases with a case fatality rate of 9.6%. Nosocomial transmission of SARS-CoV was common while the primary reservoir was putatively bats, although unproven as the actual source and the intermediary source was civet cats in the wet markets in Guangdong (Hui and Zumla, 2019). MERS is a novel lethal zoonotic disease of humans endemic to the Middle East, caused by MERS-CoV. Humans are thought to acquire MERS-CoV infection though contact with camels or camel products with a case fatality rate close to 35% while nosocomial transmission is also a hallmark (Azhar et al., 2019). The recent outbreak of clusters of viral pneumonia due to a 2019-nCoV in the Wuhan market poses significant threats to international health and may be related to sale of bush meat derived from wild or captive sources at the seafood market. As of 10 Jan 2020, 41 patients have been diagnosed to have infection by the 2019-nCoV animals. The onset of illness of the 41 cases ranges from 8 December 2019 to 2 January 2020. Symptoms include fever (>90% cases), malaise, dry cough (80%), shortness of breath (20%) and respiratory distress (15%). The vital signs were stable in most of the cases while leucopenia and lymphopenia were common. Among the 41 cases, six patients have been discharged, seven patients are in critical care and one died, while the remaining patients are in stable condition. The fatal case involved a 61 year-old man with an abdominal tumour and cirrhosis who was admitted to a hospital due to respiratory failure and severe pneumonia. The diagnoses included severe pneumonia, acute respiratory distress syndrome, septic shock and multi-organ failure. The 2019-nCoV infection in Wuhan appears clinically milder than SARS or MERS overall in terms of severity, case fatality rate and transmissibility, which increases the risk of cases remaining undetected. There is currently no clear evidence of human to human transmission. At present, 739 close contacts including 419 healthcare workers are being quarantined and monitored for any development of symptoms (WHO, 2020b, Center for Health Protection and HKSAR, 2020). No new cases have been detected in Wuhan since 3 January 2020. However the first case outside China was reported on 13th January 2020 in a Chinese tourist in Thailand with no epidemiological linkage to the Huanan Seafood Wholesale Market. The Chinese Health Authorities have carried out very appropriate and prompt response measures including active case finding, and retrospective investigations of the current cluster of patients which have been completed; The Huanan Seafood Wholesale Market has been temporarily closed to carry out investigation, environmental sanitation and disinfection; Public risk communication activities have been carried out to improve public awareness and adoption of self-protection measures. Technical guidance on novel coronavirus has been developed and will continue to be updated as additional information becomes available. However, many questions about the new coronavirus remain. While it appears to be transmitted to humans via animals, the specific animals and other reservoirs need to be identified, the transmission route, the incubation period and characteristics of the susceptible population and survival rates. At present, there is however very limited clinical information of the 2019-nCoV infection and data are missing in regard to the age range, animal source of the virus, incubation period, epidemic curve, viral kinetics, transmission route, pathogenesis, autopsy findings and any treatment response to antivirals among the severe cases. Once there is any clue to the source of animals being responsible for this outbreak, global public health authorities should examine the trading route and source of movement of animals or products taken from the wild or captive conditions from other parts to Wuhan and consider appropriate trading restrictions or other control measures to limit. The rapid identification and containment of a novel coronavirus virus in a short period of time is a re-assuring and a commendable achievement by China’s public health authorities and reflects the increasing global capacity to detect, identify, define and contain new outbreaks. The latest analysis show that the Wuhan CoV cluster with the SARS CoV.10 (Novel coronavirus - China (01): (HU) WHO, phylogenetic tree Archive Number: 20200112.6885385). This outbreak brings back memories of the novel coronavirus outbreak in China, the severe acute respiratory syndrome (SARS) in China in 2003, caused by a novel SARS-CoV-coronavirus (World Health Organization, 2019a). SARS-CoV rapidly spread from southern China in 2003 and infected more than 3000 people, killing 774 by 2004, and then disappeared – never to be seen again. However, The Middle East Respiratory Syndrome (MERS) Coronavirus (MERS-CoV) (World Health Organization, 2019b), a lethal zoonotic pathogen that was first identified in humans in the Kingdom of Saudi Arabia (KSA) in 2012 continues to emerge and re-emerge through intermittent sporadic cases, community clusters and nosocomial outbreaks. Between 2012 and December 2019, a total of 2465 laboratory-confirmed cases of MERS-CoV infection, including 850 deaths (34.4% mortality) were reported from 27 countries to WHO, the majority of which were reported by KSA (2073 cases, 772 deaths. Whilst several important aspects of MERS-CoV epidemiology, virology, mode of transmission, pathogenesis, diagnosis, clinical features, have been defined, there remain many unanswered questions, including source, transmission and epidemic potential. The Wuhan outbreak is a stark reminder of the continuing threat of zoonotic diseases to global health security. More significant and better targeted investments are required for a more concerted and collaborative global effort, learning from experiences from all geographical regions, through a ‘ONE-HUMAN-ENIVRONMENTAL-ANIMAL-HEALTH’ global consortium to reduce the global threat of zoonotic diseases (Zumla et al., 2016). Sharing experience and learning from all geographical regions and across disciplines will be key to sustaining and further developing the progress being made. Author declarations All authors have a specialist interest in emerging and re-emerging pathogens. FN, RK, OD, GI, TDMc, CD and AZ are members of the Pan-African Network on Emerging and Re-emerging Infections (PANDORA-ID-NET) funded by the European and Developing Countries Clinical Trials Partnership the EU Horizon 2020 Framework Programme for Research and Innovation. AZ is a National Institutes of Health Research senior investigator. All authors declare no conflicts of interest.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Public Health
                Front Public Health
                Front. Public Health
                Frontiers in Public Health
                Frontiers Media S.A.
                2296-2565
                17 February 2021
                2020
                17 February 2021
                : 8
                : 596913
                Affiliations
                [1] 1Department of Economics and Finance/Sustainable Real Estate Research Center, Hong Kong Shue Yan University , North Point, Hong Kong
                [2] 2School of Sciences, European University of Cyprus , Engomi, Cyprus
                [3] 3Wolfson College, Oxford University , Oxford, United Kingdom
                [4] 4Institute of Biomedical and Environmental Science and Technology, University of Bedfordshire , Luton, United Kingdom
                [5] 5School of Life Sciences, Shanxi University , Taiyuan, China
                Author notes

                Edited by: Mihajlo Michael Jakovljevic, Hosei University, Japan

                Reviewed by: Ana Sabo, University of Novi Sad, Serbia; Márta Péntek, Óbuda University, Hungary; Zafer Çaliskan, Hacettepe University, Turkey; Judit Sándor, Central European University, Hungary

                *Correspondence: Rita Yi Man Li ymli@ 123456hksyu.edu

                This article was submitted to Health Economics, a section of the journal Frontiers in Public Health

                Article
                10.3389/fpubh.2020.596913
                7925403
                e68f729b-4518-4dd5-8baa-6da4e400a1f0
                Copyright © 2021 Li, Yue and Crabbe.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 20 August 2020
                : 30 December 2020
                Page count
                Figures: 1, Tables: 0, Equations: 0, References: 27, Pages: 5, Words: 2831
                Categories
                Public Health
                Opinion

                covid-19,city management,wuhan,health policy,socialism
                covid-19, city management, wuhan, health policy, socialism

                Comments

                Comment on this article